RUNX3 and gastric cancer: RUNX3 was reported to be involved in transforming growth factor β (TGF‐β)‐induced growth inhibition in gastric cancer cells: upon TGF‐β stimulation, RUNX3 cooperates with Smad proteins to increase transcription of a cyclin‐dependent kinase inhibitor p21.12